ATE311177T1 - Orale pharmazeutische zusammensetzungen, die langkettige triglyceride und lipophile tenside enthalten - Google Patents

Orale pharmazeutische zusammensetzungen, die langkettige triglyceride und lipophile tenside enthalten

Info

Publication number: ATE311177T1
Authority: AT; Austria
Prior art keywords: long chain; pharmaceutical compositions; active ingredient; contain; drug
Prior art date: 1999-04-01

Application number

AT00919874T

Other languages

English (en)

Inventor

Elizabeth A Perry

Susan Chandler

Josephine Joan Chri Ferdinando

Nijs Henrik De

Original Assignee

Scherer Corp R P

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-01

Filing date

2000-03-29

Publication date

2005-12-15

2000-03-29 Application filed by Scherer Corp R P filed Critical Scherer Corp R P

2005-12-15 Application granted granted Critical

2005-12-15 Publication of ATE311177T1 publication Critical patent/ATE311177T1/de

Links

239000004094 surface-active agent Substances 0.000 title abstract 2
239000008203 oral pharmaceutical composition Substances 0.000 title 1
150000003626 triacylglycerols Chemical class 0.000 title 1
239000007788 liquid Substances 0.000 abstract 5
239000004480 active ingredient Substances 0.000 abstract 3
229940079593 drug Drugs 0.000 abstract 3
239000003814 drug Substances 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
125000004432 carbon atom Chemical group C* 0.000 abstract 1
235000021588 free fatty acids Nutrition 0.000 abstract 1
125000005456 glyceride group Chemical group 0.000 abstract 1
239000007887 hard shell capsule Substances 0.000 abstract 1
150000004668 long chain fatty acids Chemical class 0.000 abstract 1
229960000746 testosterone undecanoate Drugs 0.000 abstract 1
UDSFVOAUHKGBEK-CNQKSJKFSA-N testosterone undecanoate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCCCCCCCC)[C@@]1(C)CC2 UDSFVOAUHKGBEK-CNQKSJKFSA-N 0.000 abstract 1
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Dispersion Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT00919874T 1999-04-01 2000-03-29 Orale pharmazeutische zusammensetzungen, die langkettige triglyceride und lipophile tenside enthalten ATE311177T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9907715.8A GB9907715D0 (en)	1999-04-01	1999-04-01	Pharmaceutical compositions
PCT/US2000/008426 WO2000059482A1 (en)	1999-04-01	2000-03-29	Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants

Publications (1)

Publication Number	Publication Date
ATE311177T1 true ATE311177T1 (de)	2005-12-15

Family

ID=10850947

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00919874T ATE311177T1 (de)	1999-04-01	2000-03-29	Orale pharmazeutische zusammensetzungen, die langkettige triglyceride und lipophile tenside enthalten

Country Status (23)

Country	Link
EP (1)	EP1173153B1 (de)
JP (1)	JP4636692B2 (de)
AT (1)	ATE311177T1 (de)
AU (1)	AU763971B2 (de)
BR (1)	BRPI0009373B8 (de)
CA (1)	CA2366754C (de)
CZ (1)	CZ301724B6 (de)
DE (1)	DE60024429T2 (de)
DK (1)	DK1173153T3 (de)
ES (1)	ES2251991T3 (de)
GB (1)	GB9907715D0 (de)
HK (1)	HK1040364B (de)
HU (1)	HU227155B1 (de)
IL (2)	IL145567A0 (de)
MX (1)	MXPA01009817A (de)
NO (1)	NO331396B1 (de)
NZ (1)	NZ514649A (de)
PL (1)	PL196823B1 (de)
RU (1)	RU2207859C1 (de)
SI (1)	SI1173153T1 (de)
TR (1)	TR200102861T2 (de)
WO (1)	WO2000059482A1 (de)
ZA (1)	ZA200108457B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20150374826A1 (en) *	1999-06-30	2015-12-31	Lipocine Inc.	Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US20030236236A1 (en) *	1999-06-30	2003-12-25	Feng-Jing Chen	Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
AUPR573001A0 (en) *	2001-06-15	2001-07-12	Glaxo Wellcome Australia Ltd	Lymphatic drug delivery system
US7125568B2 (en)	2001-08-23	2006-10-24	Sung Michael T	Lipophilic drug compositions
KR100533460B1 (ko) *	2002-07-20	2005-12-08	대화제약 주식회사	난용성 약물의 가용화용 점막흡착성 조성물, 이를 이용한난용성 약물의 가용화용 제형 및 이들의 제조 방법
KR100533458B1 (ko)	2002-07-20	2005-12-07	대화제약 주식회사	파클리탁셀의 가용화용 조성물 및 그의 제조 방법
US20040191207A1 (en) *	2003-03-31	2004-09-30	Lipari John M.	Alpha-hydroxy acid ester drug delivery compositions and methods of use
AU2004264958B2 (en)	2003-08-13	2010-04-15	Biocon, Ltd	Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
US8492369B2 (en)	2010-04-12	2013-07-23	Clarus Therapeutics Inc	Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
CA2604943C (en) *	2005-04-15	2013-09-17	Clarus Therapeutics, Inc.	Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
CN1853728A (zh) *	2005-04-19	2006-11-01	上海天博生物科技有限公司	一种改善药物或营养物口服吸收的方法、配方及其应用
JP4889262B2 (ja)	2005-08-19	2012-03-07	理研ビタミン株式会社	脂溶性薬剤組成物
GB0807605D0 (en)	2008-04-28	2008-06-04	Diurnal Ltd	Lipid composition
US11304960B2 (en) *	2009-01-08	2022-04-19	Chandrashekar Giliyar	Steroidal compositions
US9375437B2 (en)	2010-06-18	2016-06-28	Lipocine Inc.	Progesterone containing oral dosage forms and kits
US9358241B2 (en)	2010-11-30	2016-06-07	Lipocine Inc.	High-strength testosterone undecanoate compositions
US9034858B2 (en)	2010-11-30	2015-05-19	Lipocine Inc.	High-strength testosterone undecanoate compositions
US20120148675A1 (en)	2010-12-10	2012-06-14	Basawaraj Chickmath	Testosterone undecanoate compositions
US8951996B2 (en) *	2011-07-28	2015-02-10	Lipocine Inc.	17-hydroxyprogesterone ester-containing oral compositions and related methods
EP2846773A4 (de) *	2012-05-10	2015-12-30	Painreform Ltd	Depotformulierungen eines lokalanästhetikums und verfahren zur herstellung davon
US9801819B2 (en)	2012-06-28	2017-10-31	Johnson & Johnson Consumer Inc.	Racecadotril compositions
RU2632441C2 (ru)	2012-06-28	2017-10-04	МакНЕЙЛ-ППС, ИНК.	Липидные композиции рацекадотрила
US20140179655A1 (en)	2012-12-20	2014-06-26	Solural Pharma ApS	Solid oral dosage form of testosterone derivative
US10245273B2 (en)	2013-12-26	2019-04-02	Clarus Therapeutics, Inc.	Oral pharmaceutical products and methods of use combining testosterone esters with hypolipidemic agents
WO2015193224A1 (en) *	2014-06-17	2015-12-23	Merck Sharp & Dohme B.V.	Stable formulations of testosterone undecanoate
ES2851332T3 (es)	2014-06-19	2021-09-06	Solural Pharma ApS	Forma sólida de dosificación oral de compuestos lipofílicos
US9498485B2 (en)	2014-08-28	2016-11-22	Lipocine Inc.	Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (en)	2014-08-28	2016-03-03	Lipocine Inc.	(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
AU2016284459B2 (en)	2015-06-22	2021-12-23	Lipocine Inc.	17-hydroxyprogesterone ester-containing oral compositions and related methods
US11559530B2 (en)	2016-11-28	2023-01-24	Lipocine Inc.	Oral testosterone undecanoate therapy
EP3716954A1 (de)	2017-11-27	2020-10-07	Umecrine Cognition AB	Pharmazeutische formulierung von 3-ethynyl-3-hydroxyandrostan-17-on-oxim
WO2020018974A1 (en)	2018-07-20	2020-01-23	Lipocine Inc.	Liver disease
US11564933B2 (en)	2019-04-12	2023-01-31	Tolmar, Inc.	Methods of treating testosterone deficiency
CN116456981A (zh) *	2020-11-19	2023-07-18	辉瑞爱尔兰制药公司	用于改善的grp抑制剂递送的组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5218811A (en) *	1975-08-01	1977-02-12	Eisai Co Ltd	Preparation of aqueous solution of fat- soluble substances
JPS61221131A (ja) *	1985-03-28	1986-10-01	Eisai Co Ltd	吸収促進したユビデカレノン含有組成物
GB9405304D0 (en) *	1994-03-16	1994-04-27	Scherer Ltd R P	Delivery systems for hydrophobic drugs
GB9415810D0 (en) *	1994-08-04	1994-09-28	Jerrow Mohammad A Z	Composition
GB9608719D0 (en) *	1996-04-26	1996-07-03	Scherer Ltd R P	Pharmaceutical compositions
HU229455B1 (en) *	1999-04-01	2013-12-30	Merck Sharp & Dohme	Formulation comprising testosteron undecanoate and castor oil

1999
- 1999-04-01 GB GBGB9907715.8A patent/GB9907715D0/en not_active Ceased
2000
- 2000-03-29 DK DK00919874T patent/DK1173153T3/da active
- 2000-03-29 HK HK02100518.1A patent/HK1040364B/en not_active IP Right Cessation
- 2000-03-29 WO PCT/US2000/008426 patent/WO2000059482A1/en not_active Ceased
- 2000-03-29 NZ NZ514649A patent/NZ514649A/en not_active IP Right Cessation
- 2000-03-29 SI SI200030794T patent/SI1173153T1/sl unknown
- 2000-03-29 AU AU40494/00A patent/AU763971B2/en not_active Expired
- 2000-03-29 HU HU0201444A patent/HU227155B1/hu unknown
- 2000-03-29 EP EP00919874A patent/EP1173153B1/de not_active Expired - Lifetime
- 2000-03-29 RU RU2001129365/14A patent/RU2207859C1/ru active
- 2000-03-29 CZ CZ20013460A patent/CZ301724B6/cs not_active IP Right Cessation
- 2000-03-29 CA CA002366754A patent/CA2366754C/en not_active Expired - Lifetime
- 2000-03-29 TR TR2001/02861T patent/TR200102861T2/xx unknown
- 2000-03-29 JP JP2000609046A patent/JP4636692B2/ja not_active Expired - Lifetime
- 2000-03-29 MX MXPA01009817A patent/MXPA01009817A/es active IP Right Grant
- 2000-03-29 ES ES00919874T patent/ES2251991T3/es not_active Expired - Lifetime
- 2000-03-29 DE DE60024429T patent/DE60024429T2/de not_active Expired - Lifetime
- 2000-03-29 IL IL14556700A patent/IL145567A0/xx active IP Right Grant
- 2000-03-29 AT AT00919874T patent/ATE311177T1/de active
- 2000-03-29 PL PL350094A patent/PL196823B1/pl unknown
- 2000-03-29 BR BRPI0009373A patent/BRPI0009373B8/pt not_active IP Right Cessation
2001
- 2001-09-23 IL IL145567A patent/IL145567A/en not_active IP Right Cessation
- 2001-09-28 NO NO20014719A patent/NO331396B1/no not_active IP Right Cessation
- 2001-10-15 ZA ZA200108457A patent/ZA200108457B/en unknown

Also Published As

Publication number	Publication date
TR200102861T2 (tr)	2004-12-21
RU2001129365A (ru)	2004-02-20
NZ514649A (en)	2003-09-26
IL145567A (en)	2006-04-10
HK1040364A1 (en)	2002-06-07
RU2207859C1 (ru)	2003-07-10
HUP0201444A2 (hu)	2002-11-28
CZ301724B6 (cs)	2010-06-02
PL196823B1 (pl)	2008-02-29
AU763971B2 (en)	2003-08-07
IL145567A0 (en)	2002-06-30
DE60024429D1 (de)	2006-01-05
NO331396B1 (no)	2011-12-12
SI1173153T1 (sl)	2006-06-30
JP2003526620A (ja)	2003-09-09
GB9907715D0 (en)	1999-05-26
CA2366754A1 (en)	2000-10-12
EP1173153A1 (de)	2002-01-23
ES2251991T3 (es)	2006-05-16
BRPI0009373B1 (pt)	2015-09-01
NO20014719D0 (no)	2001-09-28
HU227155B1 (en)	2010-09-28
HUP0201444A3 (en)	2004-05-28
MXPA01009817A (es)	2002-07-30
CA2366754C (en)	2009-07-14
EP1173153B1 (de)	2005-11-30
WO2000059482A1 (en)	2000-10-12
CZ20013460A3 (cs)	2002-06-12
DK1173153T3 (da)	2006-02-20
ZA200108457B (en)	2004-02-12
DE60024429T2 (de)	2006-08-03
JP4636692B2 (ja)	2011-02-23
NO20014719L (no)	2001-10-24
PL350094A1 (en)	2002-11-04
BRPI0009373B8 (pt)	2021-05-25
AU4049400A (en)	2000-10-23
BR0009373A (pt)	2002-01-29
EP1173153A4 (de)	2002-01-30
HK1040364B (en)	2006-02-10

Legal Events

Date

Code

Title

Description

2006-08-15

UEP

Publication of translation of european patent specification

Ref document number: 1173153

Country of ref document: EP

Publication	Publication Date	Title
ATE311177T1 (de)	2005-12-15	Orale pharmazeutische zusammensetzungen, die langkettige triglyceride und lipophile tenside enthalten
ATE207346T1 (de)	2001-11-15	Orale pharmazeutische zusammensetzungen mit sexualhormonen
ES2174814T3 (es)	2002-11-16	Acidos grasos esenciales destinados en la prevencion de accidentes cardio-vasculares.
PT1189620E (pt)	2004-10-29	Formulacao que compreende undecanoato de testosterona e oleo de ricino
ATE122881T1 (de)	1995-06-15	Zweiphasige freigabezusammensetzungen für lipophile wirkstoffe.
AR017801A1 (es)	2001-10-24	Una composicion de preconcentrado en microemulsion que contiene ciclosporina, y una formulacion farmaceutica que la comprende
JP2002541111A5 (de)	2007-04-05
RU2001129362A (ru)	2003-08-27	Композиция, включающая ундеканоат тестостерона и касторовое масло
KR950031039A (ko)	1995-12-18	경구 투여 약제용 제제
ES2215101T3 (es)	2004-10-01	Formulaciones farmaceuticas que contienen productos activos antiinflamatorios, y su empleo.
MY130474A (en)	2007-06-29	Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants
TH18778A (th)	1996-05-29	สูตรผสมสำหรับสารทางเคมีเภสัชศาสตร์ที่ให้ทางปาก
AR023235A1 (es)	2002-09-04	Formulaciones de androgenos